Cornelius Clancy is an Infectious Disease physician. OpenAlex indexes 393 publications with 27,995 citations (h-index 77); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-265-0606Registry record last updated 14 Feb 2008.
Clinical trials
- Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)
Sponsor: University of Pittsburgh
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- La Jolla Pharmaceutical CompanyProgram year20252 payments
- Melinta Therapeutics, LLCProgram year20251 payment
- Shionogi IncProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2000–2007 per NIH RePORTER. The latest:
- Identification of In Vivo Induced A. fumigatus Antigens
University of Florida
FY2007$39,610P01AI061537 - Identification of In Vivo Induced A. fumigatus Antigens
University of Florida
FY2006$97,544P01AI061537 - Identification of In Vivo Induced A. fumigatus Antigens
University of Florida
FY2005$97,073P01AI061537
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases
2025 - Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
The Lancet Respiratory Medicine
2024 - Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
Clinical Infectious Diseases
2023 - Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and <i>Pseudomonas aeruginosa</i> with Difficult-to-Treat Resistance (DTR-<i>P. aeruginosa</i>)
Clinical Infectious Diseases
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”